Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection

This position statement of the Department of Hypertension of the Brazilian Society of Nephrology (SBN) addresses the controversy surrounding the use or suspension/replacement of the renin-angiotensin-aldosterone system blockers (particularly inhibitors of the angiotensin-converting enzyme or angiote...

Descripción completa

Detalles Bibliográficos
Autor principal: Rodrigues, Cibele Isaac Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Nefrologia 2020
Materias:
Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479982/
https://www.ncbi.nlm.nih.gov/pubmed/32877500
http://dx.doi.org/10.1590/2175-8239-JBN-2020-S112
_version_ 1783580349213704192
author Rodrigues, Cibele Isaac Saad
author_facet Rodrigues, Cibele Isaac Saad
author_sort Rodrigues, Cibele Isaac Saad
collection PubMed
description This position statement of the Department of Hypertension of the Brazilian Society of Nephrology (SBN) addresses the controversy surrounding the use or suspension/replacement of the renin-angiotensin-aldosterone system blockers (particularly inhibitors of the angiotensin-converting enzyme or angiotensin II AT1 receptor blockers) prophylactically in individuals using these drugs, due to the possibility of allegedly worsening the prognosis of hypertensive patients infected with SARS-CoV-2. The SBN Hypertension Department recommends individualizing treatment and maintaining these medications until better scientific evidence is available.
format Online
Article
Text
id pubmed-7479982
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Nefrologia
record_format MEDLINE/PubMed
spelling pubmed-74799822020-09-17 Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection Rodrigues, Cibele Isaac Saad J Bras Nefrol Recommendations This position statement of the Department of Hypertension of the Brazilian Society of Nephrology (SBN) addresses the controversy surrounding the use or suspension/replacement of the renin-angiotensin-aldosterone system blockers (particularly inhibitors of the angiotensin-converting enzyme or angiotensin II AT1 receptor blockers) prophylactically in individuals using these drugs, due to the possibility of allegedly worsening the prognosis of hypertensive patients infected with SARS-CoV-2. The SBN Hypertension Department recommends individualizing treatment and maintaining these medications until better scientific evidence is available. Sociedade Brasileira de Nefrologia 2020-08-26 2020 /pmc/articles/PMC7479982/ /pubmed/32877500 http://dx.doi.org/10.1590/2175-8239-JBN-2020-S112 Text en https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Recommendations
Rodrigues, Cibele Isaac Saad
Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_full Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_fullStr Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_full_unstemmed Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_short Position Paper of the Department of Hypertension of the Brazilian Society of Nephrology: Use of renin-angiotensin system blockers during the course of Covid-19 infection
title_sort position paper of the department of hypertension of the brazilian society of nephrology: use of renin-angiotensin system blockers during the course of covid-19 infection
topic Recommendations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479982/
https://www.ncbi.nlm.nih.gov/pubmed/32877500
http://dx.doi.org/10.1590/2175-8239-JBN-2020-S112
work_keys_str_mv AT rodriguescibeleisaacsaad positionpaperofthedepartmentofhypertensionofthebraziliansocietyofnephrologyuseofreninangiotensinsystemblockersduringthecourseofcovid19infection

Ejemplares similares